Literature DB >> 3871366

Nonspecific immune modulating effects of ascites fluid and hyperimmune sera in vivo.

F Nagase, N M Ponzio, C Waltenbaugh, I Katz, G J Thorbecke.   

Abstract

To determine whether the appearance of interferon (IFN) and the modulation of humoral responses observed following injection of irradiated tumor cells were mediated by suppressor cells, the effects of in vivo injection of I-Js specific antibodies were studied. We found that anti-I-J-containing, as well as normal ascites fluids, obtained after repeated ip injection of complete Freund's adjuvant, contain a factor which (a) induces the appearance of serum IFN, (b) enhances the response to SRBC, and (c) suppresses the response to TNP-Ficoll, when injected 1 day before antigen. This effect is not immunologically specific, is probably not caused by intact Ig, and does not appear to be mediated by T cells. Although the nature of the factor(s) responsible for the observed results has not been fully clarified, we report these findings now as a cautionary note for the interpretation of studies where in vivo injection of unfractionated ascites fluids containing monoclonal antibodies are used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871366     DOI: 10.1016/0008-8749(85)90172-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Hypothesis: selective ineffective humoral immune responsiveness as a possible cause of certain chronic inflammatory disorders. Theoretical considerations and rationale for treatment.

Authors:  A Hässig; H Cottier
Journal:  Klin Wochenschr       Date:  1986-05-02

2.  Anti-Listeria monocytogenes immunity in mu-suppressed mice: a comparison of treatment with conventional hyperimmune rabbit anti-mouse IgM and affinity-purified, monoclonal rat anti-mouse IgM.

Authors:  A Cerny; A W Hügin; H Bazin; S Sutter; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.